Pancreatic cancer is known as the world’s toughest cancer. In fact, it is the third deadliest cancer, on target to become the second by 2030. Over the past 50 years, we’ve seen only marginal improvements in survival and yet it remains one of the most overlooked and underfunded cancers. Too many people are told to go home and get their affairs in order when they receive the devastating diagnosis of pancreatic cancer. Pancreatic Cancer North America, together with our partners at Pancreatic Cancer Canada, have decided that enough is enough.

We’ve raised enough sympathy – it is time to raise survival rates.

In the past 50 years, the survival rate for pancreatic cancer has only improved by 13%. This is not meaningful progress, and patients cannot rely on hope alone to live through this deadly disease.  Pancreatic Cancer North America aims to disrupt the traditional approach to discovery in pancreatic cancer by bringing together multiple sectors, innovations, and novel methods to drive real change.

Pancreatic Cancer North America is committed to working with all partners who believe as we do in coming together boldly to change the outcome for the world’s toughest cancer.